相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche
Pilar Baldominos et al.
CELL (2022)
Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer
Courtney T. Stump et al.
OPEN BIOLOGY (2021)
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes
Kevin Roehle et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Checkpoint blockade toxicities: Insights into autoimmunity and treatment
Michael J. Walsh et al.
SEMINARS IN IMMUNOLOGY (2021)
Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes
Tao Peng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade
Davis Y. Torrejon et al.
CANCER DISCOVERY (2020)
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Noor Momin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2019)
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
Bradley N. Mills et al.
CELL REPORTS (2019)
Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy
Anandaroop Mukhopadhyay et al.
GENE THERAPY (2019)
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Jan B. Boscheinen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
Dipongkor Saha et al.
CLINICAL CANCER RESEARCH (2018)
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma
Hiroshi Nakashima et al.
CLINICAL CANCER RESEARCH (2018)
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li et al.
IMMUNITY (2018)
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
Caroline Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mechanisms of Host IFI16, PML, and Daxx Protein Restriction of Herpes Simplex Virus 1 Replication
Philipp E. Merkl et al.
JOURNAL OF VIROLOGY (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Detection and removal of barcode swapping in single-cell RNA-seq data
Jonathan A. Griffiths et al.
NATURE COMMUNICATIONS (2018)
Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs
Michael Dougan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
Valerio Leoni et al.
PLOS PATHOGENS (2018)
Comprehensive network map of interferon gamma signaling
Mohd Younis Bhat et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8(+) T Cell-Effector Responses
Eleanor Clancy-Thompson et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Thomas Kammertoens et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
Pengju Wang et al.
NATURE COMMUNICATIONS (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells
Sabrina Thomann et al.
IMMUNOLOGY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Ontogeny of tissue-resident macrophages
Guillaume Hoeffel et al.
FRONTIERS IN IMMUNOLOGY (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Enhanced Antitumor Response Mediated by the Codelivery of Paclitaxel and Adenoviral Vector Expressing IL-12
Linjie Cao et al.
MOLECULAR PHARMACEUTICS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Transnuclear TRP1-Specific CD8 T Cells with High or Low Affinity TCRs Show Equivalent Antitumor Activity
Stephanie K. Dougan et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission
Barbara Lohman-Payne et al.
AIDS (2012)
Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
Michele W. L. Teng et al.
CANCER RESEARCH (2012)
Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
Jose I. Quetglas et al.
MOLECULAR THERAPY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein
Megan H. Orzalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users
J. K. Flynn et al.
JOURNAL OF VIRAL HEPATITIS (2011)
IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46
Maya Eisenring et al.
NATURE IMMUNOLOGY (2010)
Genetic engineering of a modified herpes simplex virus 1 vaccine vector
XueQiao Liu et al.
VACCINE (2009)
IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Bin Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems
Simon B. Rasmussen et al.
JOURNAL OF VIROLOGY (2007)
Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector
Daisuke Watanabe et al.
VIROLOGY (2007)
Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells
Ayuko Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-γ production
KD Mayer et al.
JOURNAL OF IMMUNOLOGY (2005)
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis
EA Kurt-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
γδ T cells provide an early source of interferon γ in tumor immunity
YF Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells
J Lund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Lentivirus-delivered stable gene silencing by RNAi in primary cells
SA Stewart et al.
RNA (2003)
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection
KM Eidson et al.
JOURNAL OF VIROLOGY (2002)
Determinants of viral clearance and persistence during acute hepatitis C virus infection
R Thimme et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1
CG Miller et al.
MOLECULAR THERAPY (2001)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
